Share issuance and capital increase through the exercise of stock acquisition rights
First written in FY2021-Q1. 13 of 14 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2024.
103 other companies' latest entry also says "Advanced".
- FY2024AdvancedAnnual report
「1 March 2023–29 February 2024 Common shares 30,100 Common shares 4,550,300 3,764 350,431 3,764 385,431」
In the fiscal year ended February 2024, 30,100 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital surplus by ¥3.764 million each. - FY2024-Q1AdvancedAnnual report
「1 March 2023–31 May 2023 30,100 4,550,300 3,764 350,431 3,764 385,431 (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the first quarter increased the number of shares by 30,100, and increased stated capital and the capital surplus by ¥3.764 million each. - FY2023AdvancedAnnual report
「1 March 2022–28 February 2023 (Note) 7 Common shares 73,300 Common shares 4,520,200 9,166 346,667 9,166 381,667 (Note) 7. Resulting from the exercise of stock acquisition rights.」
In the fiscal year ended February 2023, 73,300 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital surplus by ¥9.166 million each. - FY2023-Q3AdvancedAnnual report
「1 September 2022–30 November 2022 (Note) 1 13,800 4,506,200 1,725 344,917 1,725 379,917 (Note) 1. Increase resulting from the exercise of stock acquisition rights. 2. Between 1 December 2022 and 31 December 2022, the exercise of stock acquisition rights increased the total number of issued shares by 14,000 and stated capital and the capital surplus by ¥1.750 million each.」
The exercise of stock acquisition rights during the third quarter increased the number of shares by 13,800, and increased stated capital and the capital surplus by ¥1.725 million each. It also reports the issuance of 14,000 shares and increases of ¥1.750 million each in December 2022. - FY2023-Q2AdvancedAnnual report
「1 June 2022–31 August 2022 (Note) 1 32,200 4,492,400 4,026 343,191 4,026 378,191 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the second quarter increased the number of shares by 32,200, and increased stated capital and the capital surplus by ¥4.026 million each. It also reports the issuance of 13,800 shares and increases of ¥1.725 million each in September. - FY2023-Q1AdvancedAnnual report
「1 March 2022–31 May 2022 (Note) 1 13,300 4,460,200 1,663 339,164 1,663 374,164 (Note) 1. Increase resulting from the exercise of stock acquisition rights. 2. Between 1 June 2022 and 30 June 2022, the exercise of stock acquisition rights increased the total number of issued shares by 32,200 and stated capital and the capital surplus by ¥4.026 million each.」
The exercise of stock acquisition rights during FY2023-Q1 increased the number of shares by 13,300, and increased stated capital and the capital surplus by ¥1.663 million each. It also reports the issuance of 32,200 shares and increases of ¥4.026 million each in June 2022. - FY2022AdvancedAnnual report
「1 March 2021–28 February 2022 (Note) 7 Common shares 92,400 Common shares 4,446,900 11,554 Common shares 337,501 (Note) 7. Resulting from the exercise of stock acquisition rights.」
In the fiscal year ended February 2022, 92,400 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital surplus by ¥11.554 million each. - FY2022-Q3AdvancedAnnual report
「1 September 2021–30 November 2021 (Note) 1 4,200 4,373,300 525 328,297 525 363,297 (Note) 1. Increase resulting from the exercise of stock acquisition rights. 2. Between 1 December 2021 and 31 December 2021, the exercise of stock acquisition rights increased the number of shares issued by 73,600 and stated capital and the capital surplus by ¥9.203 million each.」
The exercise of stock acquisition rights during FY2022-Q3 increased the number of shares by 4,200, and increased stated capital and the capital surplus by ¥525 thousand each. It also reports the issuance of 73,600 shares and increases of ¥9.203 million each in December 2021. - FY2022-Q2AdvancedAnnual report
「1 June 2021–31 August 2021 (Note) 1 4,300 4,369,100 537 327,772 537 362,772 (Note) 1. The increase resulted from the exercise of stock acquisition rights. 2. Between 1 September and 30 September 2021, the exercise of stock acquisition rights increased the total number of issued shares by 4,200 and share capital and the capital reserve by ¥525 thousand each.」
The exercise of stock acquisition rights during FY2022-Q2 increased the number of shares by 4,300, and increased stated capital and the capital surplus by ¥537 thousand each. It also reports the issuance of 4,200 shares and increases of ¥525 thousand each in September 2021. - FY2022-Q1AdvancedAnnual report
「1 March 2021–31 May 2021 (Note) 1 10,300 4,364,800 1,288 327,235 1,288 362,235 (Note) 1. The increase resulted from the exercise of stock acquisition rights. 2. Between 1 June and 30 June 2021, the exercise of stock acquisition rights increased the total number of issued shares by 4,300 and share capital and the capital reserve by ¥1,075 thousand each.」
During FY2022-Q1, 10,300 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital reserve by ¥1,288 thousand each. The disclosure also states that in June 2021, 4,300 shares were issued and each of share capital and the capital reserve increased by ¥1,075 thousand. - FY2021AdvancedAnnual report
「1 March 2020–28 February 2021 (Note) 7 Common shares 75,800 Common shares 4,354,500 9,478 Common shares 360,946 (Note) 7. The increase resulted from the exercise of stock acquisition rights.」
During the fiscal year ended February 2021, 75,800 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital reserve by ¥9,478 thousand each. - FY2021-Q3AdvancedAnnual report
「1 September 2020–30 November 2020 3,800 4,292,500 475 318,193 475 353,193 (Note) 1. The increase resulted from the exercise of stock acquisition rights. 2. Between 1 December and 31 December 2020, the exercise of stock acquisition rights increased the total number of issued shares by 62,000 and share capital and the capital reserve by ¥7,753 thousand each.」
During the third quarter, 3,800 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital reserve by ¥475 thousand each. The disclosure also states that in December, 62,000 shares were issued and each of share capital and the capital reserve increased by ¥7,753 thousand. - FY2021-Q2AdvancedAnnual report
「1 June 2020–31 August 2020 1,400 4,288,700 175 317,718 175 352,718 (Note) 1. The increase resulted from the exercise of stock acquisition rights. 2. Between 1 September and 30 September 2020, the exercise of stock acquisition rights increased the total number of issued shares by 3,800 and share capital and the capital reserve by ¥475 thousand each.」
During the second quarter, 1,400 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital reserve by ¥175 thousand each. The disclosure also states that in September, before the filing date, 3,800 shares were issued and each of share capital and the capital reserve increased by ¥475 thousand. - FY2021-Q1First statedAnnual report
「1 March 2020–31 May 2020 8,600 4,287,300 1,075 317,543 1,075 352,543 (Note) 1. The increase resulted from the exercise of stock acquisition rights.」
During the first quarter under review, 8,600 shares were issued through the exercise of stock acquisition rights, increasing share capital and the capital reserve by ¥1,075 thousand each. The disclosure also states that 1,400 shares were issued in June 2020, increasing share capital and the capital reserve by ¥175 thousand each.